NanoTemper named one of Germany’s most innovative companies in 2021 by Capital

April 28, 2021 Stefanie Kall

For the second year in a row, NanoTemper was named one of the most innovative companies in Germany by Capital magazine. A five out of five star distinction placed NanoTemper in the ranking’s top quartile for innovation. And, with 76 of the 473 award-winning companies hailing from the Munich region, NanoTemper’s global headquarters is in an innovation hotspot.

More than 3200 experts were surveyed and asked to rate how innovative companies in their sectors were, ranging from the automotive and financial sector to the communications and technology industries. Notably, many of the winners for 2021 were pharmaceutical and tech companies. Biotech, especially, launched into the forefront of everyday people’s lives, and these companies were ready to respond to this need despite the limitations of the pandemic lockdowns.


“Our company has a crucial role in supporting those performing diagnostic and vaccine research during the pandemic, but we also have a responsibility to keep our own employees safe while moving forward. We struck that careful balance and continued to develop new products, like the Prometheus Panta, to help researchers do science that matters” — Philipp Baaske, co-CEO of NanoTemper


While innovation at NanoTemper is driven by a strong production, operations, and R&D team based out of the Munich headquarters, the company has offices in biotech hotspots all over the world, including the Bay Area, Boston, London, Shanghai, Beijing, Tokyo, and Bangalore. This physical presence is another key to innovative success according to co-CEO Dr. Stefan Duhr, “Our international locations and close connections to our customers allows us to identify their needs and pain points and thus to develop the best tools for them.”

Read the latest news and announcements from NanoTemper here.

Previous Article
NanoTemper and SIRION Biotech support Adrian Bleninger’s bid for round-the-world sailing race, the Vendée Globe
NanoTemper and SIRION Biotech support Adrian Bleninger’s bid for round-the-world sailing race, the Vendée Globe

NanoTemper Technologies and SIRION Biotech, two of Munich’s rapidly growing biotech companies, are lending ...

Up next
Protein degraders show promising results in drug development pipelines. See progress candidates have made.
Protein degraders show promising results in drug development pipelines. See progress candidates have made.

There has been considerable and promising development in the field of targeted protein degradation (TPD) si...

Have a question?

Contact Specialist
×

Sign up to receive
the latest NanoTemper news, product updates, event announcements and more

First Name
Last Name
Company Name
Country
State
Province
State
Region
State
Canton
Agree to Subscribe & Privacy Policy*
*I have fully read, understood and agree to the Privacy Policy. I accept the storing and processing of my personal data by NanoTemper as described in the Privacy Policy.

By completing this form, you provide us consent to contact you with educational content, news and information about our products, services and events. You may unsubscribe at any time.
Thank you!
Error - something went wrong!